Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer. [electronic resource]
Producer: 20180212Description: 1265-1278 p. digitalISSN:- 1573-675X
- Animals
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cisplatin -- administration & dosage
- Drug Resistance, Neoplasm -- drug effects
- Drugs, Chinese Herbal -- administration & dosage
- Flavanones -- administration & dosage
- Glutathione Transferase -- genetics
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- NF-E2-Related Factor 2 -- genetics
- Reactive Oxygen Species -- metabolism
- Scutellaria baicalensis -- chemistry
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.